Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Dialysis Solution Recalled
09/08/2023
Jolynn Tumolo
A class II recall has been issued for more than 500,000 bottles of Dianeal Low Calcium peritoneal dialysis solution because of a lack of assurance of sterility.
A class II recall has been issued for more than 500,000 bottles of Dianeal Low Calcium peritoneal dialysis solution because of a lack of assurance of sterility.
A class II recall has been...
09/08/2023
Pharmacy Learning Network
News
Artificial Intelligence May Influence Whether Patients Can Get Pain Medication
09/06/2023

Andy Miller and Sam Whitehead, KFF Health News

Andy Miller and Sam Whitehead, KFF He...
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data, but experts have raised questions about how these systems work and worry about their accuracy and...
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data, but experts have raised questions about how these systems work and worry about their accuracy and...
To contain the opioid crisis,...
09/06/2023
Pharmacy Learning Network

Advertisement

News
Subpotent Blood Pressure Drug Recalled
09/01/2023
Jolynn Tumolo
Glenmark Pharmaceuticals Inc. is recalling 1200 bottles of trandolapril and verapamil hydrochloride extended-release tablets for subpotency. According to the August 30, 2023, US Food and Drug Administration (FDA) Enforcement Report, samples...
Glenmark Pharmaceuticals Inc. is recalling 1200 bottles of trandolapril and verapamil hydrochloride extended-release tablets for subpotency. According to the August 30, 2023, US Food and Drug Administration (FDA) Enforcement Report, samples...
Glenmark Pharmaceuticals Inc. is...
09/01/2023
Pharmacy Learning Network
News
Anticonvulsant Recalled
09/01/2023
Jolynn Tumolo
Aurobindo Pharma USA Inc. is pulling 96 bottles of rufinamide tablets that were released prior to approval, according to the August 30, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Aurobindo Pharma USA Inc. is pulling 96 bottles of rufinamide tablets that were released prior to approval, according to the August 30, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Aurobindo Pharma USA Inc. is...
09/01/2023
Pharmacy Learning Network
News
Chemotherapy Drug Recalled
09/01/2023
Jolynn Tumolo
Baxter Healthcare Corporation is recalling 13,502 vials of bendamustine hydrochloride injection after a customer reported vials with peeling labels, according to the August 30, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Baxter Healthcare Corporation is recalling 13,502 vials of bendamustine hydrochloride injection after a customer reported vials with peeling labels, according to the August 30, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Baxter Healthcare Corporation is...
09/01/2023
Pharmacy Learning Network

Advertisement

News
Report Describes Oncology Pharmacy Practice Landscape in United States
08/25/2023
Jolynn Tumolo
Results from a national survey of Hematology/Oncology Pharmacy Association members revealed that most oncology treatments happen in outpatient settings, with the highest number of oncology pharmacist full-time equivalents dedicated to...
Results from a national survey of Hematology/Oncology Pharmacy Association members revealed that most oncology treatments happen in outpatient settings, with the highest number of oncology pharmacist full-time equivalents dedicated to...
Results from a national survey...
08/25/2023
Pharmacy Learning Network
News
Clinical Pharmacy Specialists Linked With Increased Use of Diabetes Drugs With Cardiovascular Benefit
08/25/2023
Jolynn Tumolo
A study found that clinical pharmacy specialists can significantly increase the prescription of diabetes drugs with cardiovascular benefits for patients with diabetes and cardiovascular risk.
A study found that clinical pharmacy specialists can significantly increase the prescription of diabetes drugs with cardiovascular benefits for patients with diabetes and cardiovascular risk.
A study found that clinical...
08/25/2023
Pharmacy Learning Network
News
Ophthalmic Antibiotic Recalled
08/25/2023
Jolynn Tumolo
A recall has been issues for over 80,000 bottles of tobramycin ophthalmic solution for failing to meet impurity/degradation specifications.
A recall has been issues for over 80,000 bottles of tobramycin ophthalmic solution for failing to meet impurity/degradation specifications.
A recall has been issues for...
08/25/2023
Pharmacy Learning Network

Advertisement

News
Studies Likely Underestimate RSV Incidence in Older Adults
08/25/2023
Jolynn Tumolo
Researchers explore the limitations in current studies on the incidence and prevalence of respiratory syncytial virus in older adults, highlighting the need for improved research methods and testing to accurately capture the impact of RSV and...
Researchers explore the limitations in current studies on the incidence and prevalence of respiratory syncytial virus in older adults, highlighting the need for improved research methods and testing to accurately capture the impact of RSV and...
Researchers explore the...
08/25/2023
Pharmacy Learning Network
News
Antiarrhythmic Capsules Recalled
08/18/2023
Jolynn Tumolo
Dofetilide capsules have been recalled due to out-of-specification results for content uniformity after bottles were distributed throughout the United States.
Dofetilide capsules have been recalled due to out-of-specification results for content uniformity after bottles were distributed throughout the United States.
Dofetilide capsules have been...
08/18/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use